Drug Topics
FEBRUARY 6, 2023
Artificial intelligence has the potential to revolutionize and improve medicine. However, in order for widespread implementation, certain challenges and obstacles must first be overcome.
STAT
FEBRUARY 6, 2023
One of the shinier entrants to have emerged in the world of mental health startups abruptly announced last week it would wind down, right in the middle of an ongoing crisis in mental health care. Mindstrong, which had raised a total of $160 million from a who’s-who of blue-chip investors, and was led for a while by a former National Institute of Mental Health director, simply couldn’t find a way to make money delivering the low-cost, high-quality care it had promised.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
FEBRUARY 6, 2023
Vaccination greatly reduces the probability of experiencing severe COVID-19 in both variants. Adults between the ages of 40 to 59 years saw the most significant reduction in risk when compared to individuals in other age categories.
Pharmaceutical Technology
FEBRUARY 6, 2023
Researchers at the Feinstein Institutes for Medical Research have discovered a new protein that can be a potential therapeutic target for lethal sepsis. Led by Feinstein Institutes researcher Haichao Wang, the new study focuses on detecting protein mediators that might contribute to uncontrolled immune responses to lethal infections. It explores the monoclonal antibody detection that may work against procathepsin-L (pCTS-L), a pro-inflammatory protein mediator, as the potential remedy.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
FEBRUARY 6, 2023
A 2021 morbidity study found that COVID-19 was among the leading causes of death in children and young people.
STAT
FEBRUARY 6, 2023
“Living With” explores the contours of life with chronic illness, from the prelude to diagnosis to new patterns of living, to wrestling with big questions about illness and health. Laura Mauldin was immersed in Deaf culture from childhood — but she’s not deaf. She went to a school that happened to educate many deaf children, and so she grew up learning American Sign Language.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
FEBRUARY 6, 2023
By the time medics arrived, Tyre Nichols was sitting on the ground, handcuffed and propped against a police car. The 29-year-old’s face was bloody and he was groaning in pain. On Jan. 7, after pulling Nichols over for a traffic stop, Memphis police officers had tased him, pepper-sprayed him, punched him, kicked him in the head, and beaten him with a baton.
Drug Topics
FEBRUARY 6, 2023
The groups released 8 recommendations to support action across the health care community.
STAT
FEBRUARY 6, 2023
The FDA’s withdrawal of its authorization for Evusheld , a monoclonal antibody therapy used to prevent and treat Covid-19, leaves no monoclonals available for this purpose. Another monoclonal, bebtelovimab, used to treat Covid-19, was withdrawn late last November. The FDA pulled its approval for these therapies because they were no longer effective against the newer SARS-CoV-2 variants circulating in the United States.
The Checkup by Singlecare
FEBRUARY 6, 2023
Anxiety and insomnia | Medications | Stopping medication | Other treatment | When to see a doctor If you experience insomnia and anxiety, you are not alone in wishing for a restful night’s sleep. Sleep problems such as insomnia affect as many as 30 to 40% of adults in a given year and is the most common sleep disorder in the United States. Insomnia can be short-term (lasting for less than 3 months), or long-term (occurring at least 3 days a week for 3 months or more).
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
FEBRUARY 6, 2023
From telehealth and TikTok to artificial intelligence and virtual reality, the mental health care industry is embracing technology — but it’s making many clinicians uneasy. From concerns about the ethics of mental health influencers to the inaccuracy of mental health advice on TikTok and to complaints about teens misdiagnosing themselves , many experts are uncomfortable about the role technology is playing in mental health support.
Drug Store News
FEBRUARY 6, 2023
Healthy Futures will support EmbraceRace’s continued creation of self-directed online resources for parents and guardians interested in learning and strengthening their caregiving practices.
STAT
FEBRUARY 6, 2023
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so-familiar routine of online meetings, conferences and deadlines has predictably returned. But what can you do? The world, such as it is, keeps spinning. So to give it a nudge in a useful direction, we are firing up the coffee kettle to brew another cup of stimulation.
Drug Store News
FEBRUARY 6, 2023
Sincerely Health, a digital health and wellness app, was designed to help improve lives by educating, connecting, encouraging and rewarding customers on their health and wellness journey.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
FEBRUARY 6, 2023
Hispanic, Latino, and non-Hispanic Black Americans on dialysis for end-stage kidney disease have a higher risk of developing life-threatening bloodstream infections, a new report says. And those racial and ethnic disparities are deepened by another risk factor: how the patient received hemodialysis. Going through a central venous catheter straight into major veins was linked to higher rates of infection than less invasive routes.
Hospital Pharmacy Europe
FEBRUARY 6, 2023
Sanjay Prasad MD has been a consultant in cardiology and cardiovascular magnetic resonance at the Royal Brompton Hospital since 2003 and is also Professor of Cardiomyopathy at Imperial College, London. His clinical and research interests focus on myocarditis and cardiomyopathy, the causes of these conditions, and treatment and risk stratification using cardiac MRI, using both a phenomic and genomic approach.
STAT
FEBRUARY 6, 2023
Japanese drugmaker Eisai reported Monday the first U.S. sales of Leqembi, its treatment for Alzheimer’s disease, although exact numbers were not provided and people taking the drug appear to be paying out of pocket because insurance coverage has not yet been established. The first U.S. sales of Leqembi were recorded on Jan. 18, Eisai said Monday during its presentation of financial results for the fiscal third quarter that ended on Dec. 31.
ISPE
FEBRUARY 6, 2023
The Senlan Bay Forum - ISPE Biopharmaceutical Engineering Summit 2022 Has Come to a Successful Conclusion! Trudy Patterson Mon, 02/06/2023 - 15:27 iSpeak Blog iSpeak The Senlan Bay Forum - ISPE Biopharmaceutical Engineering Summit 2022 Has Come to a Successful Conclusion! 6 February 2023 On December 9-10, 2022, the two-day Senlan Bay Forum – ISPE Biopharmaceutical Engineering Summit 2022 was successfully held in Shanghai Peony Garden!
STAT
FEBRUARY 6, 2023
When Betelihem Alemayehu moved with her parents from the countryside of Ethiopia to Boston nearly a decade ago, she didn’t know how to ride the T, she couldn’t speak English, and she could never have guessed that one day she’d be employed in one of the city’s cutting-edge industries. Alemayehu, now 22, works in lab operations at Vedanta Biosciences, a Cambridge biotech startup that’s unraveling the mysteries of the human microbiome to create drugs from helpful
Fierce Healthcare
FEBRUARY 6, 2023
CVS closing in on deal to buy Oak Street Health to expand primary care footprint: WSJ report hlandi Mon, 02/06/2023 - 22:19
STAT
FEBRUARY 6, 2023
Sage Therapeutics said Monday that U.S. regulators accepted a marketing application for its rapid-acting antidepressant and granted it priority review with a decision date set for early August. The Food and Drug Administration will assess the efficacy and safety of the Sage drug, a once-daily pill called zuranolone, for the treatment of people with major depressive disorder and postpartum depression.
Fierce Healthcare
FEBRUARY 6, 2023
Experts sound alarm on 'preventable public health crisis' as virtual prescribing for opioid use disorder now in limbo aburky Mon, 02/06/2023 - 18:17
European Pharmaceutical Review
FEBRUARY 6, 2023
EXS4318 (‘4318), a potentially first-in-class, potent and selective PKC theta inhibitor has entered first-in-human Phase I trials in the US. The compound is in development for immunology and inflammation indications. PKC theta plays a critical role in controlling T cell function and is a key driver of several highly prevalent autoimmune diseases.
Drug Store News
FEBRUARY 6, 2023
Harris Teeter is inviting diverse product suppliers to apply to join a virtual Supplier Diversity Summit that will occur from March 28 to 30.
European Pharmaceutical Review
FEBRUARY 6, 2023
In a recent Phase II study , FT011, a novel, first-in-class oral therapy for chronic fibrosis in multiple organs showed meaningful improvements in over 60 percent of scleroderma patients after 12 weeks. FT011 is a novel biologic target in the fibrosis mechanism as a defined G protein-coupled receptor (GPCR). This GPCR is silent in healthy tissue but activated following injury or disease.
Drug Store News
FEBRUARY 6, 2023
Drug Store News spoke to Meg Bedford, CEO of Loops, about its retail partnership with Target and what it means for the future of the brand.
Fierce Pharma
FEBRUARY 6, 2023
Led by Merck, Vertex and Lilly, pharma's share prices largely climbed in '22 despite economic angst kdunleavy Tue, 02/07/2023 - 00:03
Fierce Healthcare
FEBRUARY 6, 2023
ShiftMed clinches $200M in fresh funding as investors bet big on healthcare staffing companies hlandi Mon, 02/06/2023 - 07:57
Fierce Pharma
FEBRUARY 6, 2023
Anatomy of a launch: As Leqembi takes first steps, Eisai maps Alzheimer's med's rollout fkansteiner Mon, 02/06/2023 - 10:06
Fierce Healthcare
FEBRUARY 6, 2023
Wyden pledges to defend drug price negotiation powers in light of pharma pushback rking Mon, 02/06/2023 - 15:46
Drug Store News
FEBRUARY 6, 2023
Kiss Lashes products were used at the 2023 Grammy Awards by Megan Fox, Heidi Klum and nominee Doja Cat.
Pharmafile
FEBRUARY 6, 2023
Pain management medical device company SPR Therapeutics has obtained expanded approval from the FDA for its SPRINT Peripheral Nerve System (PNS) System. The SPRINT PNS System is a 60-day treatment which reconditions the central nervous system (CNS) without the need for a permanent implant, any nerve destruction or risk of addiction to pain medication.
Drug Store News
FEBRUARY 6, 2023
The acquisition expands Kadenwood's premium portfolio of plant-based wellness products.
Fierce Healthcare
FEBRUARY 6, 2023
Report: Only quarter of hospitals analyzed complied with key price transparency rule rking Mon, 02/06/2023 - 11:09
Expert insights. Personalized for you.
201 
Let's personalize your content